New Omicron variant vaccine being trialled by Pfizer-BioNTech | 7NEWS

7NEWS Australia published this video item, entitled “New Omicron variant vaccine being trialled by Pfizer-BioNTech | 7NEWS” – below is their description.

A new COVID vaccine is being trialled by Pfizer to better protect against Omicron. The pharmaceutical giant, and German partner Biontech, are giving the new jab to 1,400 people. But some experts believe that it might not be needed.

7NEWS Australia YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.


About This Source - 7NEWS Australia

Seven News is the television news service of the Seven Network and, as of 2016, the highest-rating in Australia. The news service draws upon overseas channels for select international coverage. The network’s Director of News and Current Affairs is Craig McPherson.

Recent from 7NEWS Australia:

Johnny Depp case: Photos of Amber Heard night after alleged attack shown to jury | 7NEWS

Sri Lanka only has one day’s worth of petrol left | 7NEWS

Education minister vowed to make sure students have the chance to catch up after COVID | 7NEWS

In This Story: BioNTech

BioNTech SE (NASDAQ: BNTX) is a German biotechnology company dedicated to the development and manufacture of active immunotherapies for a patient-specific approach to the treatment of serious diseases.

5 Recent Items: BioNTech

Biden Gets His Second Covid Booster Shot

Europe refuses to drop vaccine patents, offering mobile vaccine plants instead | DW News

BioNTech to ship vaccine factory kits to Africa | DW News

Pfizer-BioNTech Co-Founders Give Exclusive Look Into Covid-19 Vaccine

Fact check: Does the omicron variant reduce vaccine efficacy? | DW News

In This Story: COVID-19

Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

Symptoms of coronavirus

The main symptoms of coronavirus are:

  • a persistent new cough (non productive, dry)
  • a high temperature (e.g. head feels warm to the touch)
  • shortness of breath (if this is abnormal for the individual, or increased)

Latest News about Covid-19

Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

5 Recent Items: COVID-19

North Korea faces health crisis amid virus surge • FRANCE 24 English

N Korea deploys army as WHO expressed ‘concern’ over COVID

Cannes film festival: 75th anniversary edition to begin • FRANCE 24 English

Shanghai bus companies prepare to resume operations

Covid-19 in North Korea: Military ramps up response effort as virus surges • FRANCE 24 English

In This Story: Omicron

The Omicron variant of Covid-19 (also known as B.1.1.529) has been declared a Variant of Concern.

The Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) is an independent group of experts that periodically monitors and evaluates the evolution of SARS-CoV-2 and assesses if specific mutations and combinations of mutations alter the behaviour of the virus. The TAG-VE was convened on 26 November 2021 to assess the SARS-CoV-2 variant: B.1.1.529 – which is known as Omicron – the group declared the variant a Variant of Concern.

5 Recent Items: Omicron

Kim Jong-un warns Covid posing ‘great turmoil’ on North Korea as deadly outbreak quickly spreads

North Korea confirms 1st COVID-19 deaths days after admitting 1st outbreak

North Korea confirms first Covid-19 death in ‘explosive’ outbreak • FRANCE 24 English

North Korea reports first official COVID-19 death | DW News

North Korea confirms COVID-19 outbreak, imposes nationwide lockdown

In This Story: Pfizer

Pfizer Inc. (NYSE: PFE) is an American multinational pharmaceutical corporation headquartered in New York City. In 2012, it was one of the world’s largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

5 Recent Items: Pfizer

Biohaven CEO discusses Pfizer’s purchase of the company

Biohaven Pharmaceuticals shares surge after Pfizer agrees to acquire company

Pfizer acquires Biohaven for $11.6 billion in cash

We’re Not Allowed To Talk About This

Pfizer will submit data on Covid-19 vaccine for kids under 5 in next few weeks, says CEO Bourla

Leave a Comment

We don't require your email address, or your name, for anyone to leave a comment. If you do add an email address, you may be notified if there are replies to your comment - we won't use it for any other purpose. Please make respectful comments, which add value, and avoid personal attacks on others. Links are not allowed in comments - 99% of spam comments, attempt to post links. Please describe where people may find additional information - for example "visit the UN website" or "search Google for..." rather than posting a link. Comments failing to adhere to these guidelines will not be published.

Posting....